Holding(s) in Company

RNS Number : 4381E
CVS Group plc
06 April 2011
 



Form TR-1 with annex. FSA Version 2.1 updated April 2007

 

For filings with the FSA include the annex

For filings with issuer exclude the annex

 

TR-1: Notifications of Major Interests in Shares

 

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

 

CVS Group Plc

 

2. Reason for notification (yes/no)

 

An acquisition or disposal of voting rights

YES

 

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


 

An event changing the breakdown of voting rights


 

Other (please specify):______________


 

3. Full name of person(s) subject to notification obligation:

 

North Atlantic Value LLP  (as investment adviser/manager)

 

4. Full name of shareholder(s) (if different from 3):

 

1. Oryx International Growth Fund Limited

 

2. North Atlantic Smaller Companies Investment Trust PLC

 

5. Date of transaction (and date on which the threshold is crossed or reached if different):

 

5 April 2011

 

6. Date on which issuer notified:

 

6 April 2011

 

7. Threshold(s) that is/are crossed or reached:

 

Through 10%

 

8: Notified Details

A: Voting rights attached to shares

 

Class/type of shares

If possible use ISIN code

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares

Number of voting rights

Percentage of voting rights

 

Direct

 

Indirect

 

Direct

 

Indirect

 

Ordinary shares

Sedol: B286382

 

 

Holder 1       3,750,000      3,750,000      3,750,000    3,750,000                            6.64%

 

Holder 2      1,852,500      1,852,500      1,909,932     1,909,932                            3.38%

 

 

                                                                                      TOTAL:                      10.02%

 

 

B: Financial Instruments

 

Resulting situation after the triggering transaction

 

Type of financial instrument

Expiration date

Exercise/ conversion period/date

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights



 

 



 

 

Total (A+B)

 

Number of voting rights

 

Percentage of voting rights

5,659,932

10.02%

 

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

 

Not applicable

 

 

Proxy Voting:

 

10. Name of proxy holder:

 

-

11. Number of voting rights proxy holder will cease to hold:

 

-

12. Date on which proxy holder will cease to hold voting rights:

 

-

 

13. Additional information:

 

North Atlantic Value LLP is the investment manager/adviser in respect of the full 10.02% holding as it is investment adviser to Holder 1 as well as Joint Manager of Holder 2.

 

14 Contact name:

 

Bonita Guntrip

15. Contact telephone name:

 

020 7747 5681

 

For notes on how to complete form TR-1 please see the FSA website.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFVSSFIRIIL

Companies

CVS Group (CVSG)
UK 100

Latest directors dealings